kras mutation and glutathion The roles of in cancer metabolism, tumor microenvironment clinical therapy | Molecular Cancer Uncovering new therapeutic targets for
Uncovering new therapeutic targets for a common KRAS mutation behind cancer Targeting KRAS Mutant Cancers with a Covalent G12C Specific Inhibitor: Cell KRAS G12D: The Next Frontier in Cancer Therapy MedChemExpress Targeting KRAS mutant stomach colorectal tumors by disrupting the ERK2 p53 complex ScienceDirect JCI Suppression of the SLC7A11 glutathione axis causes synthetic lethality in KRAS mutant lung adenocarcinoma Frontiers KRAS mutation: The booster of pancreatic ductal adenocarcinoma transformation and progression
Pay in 4 interest-free payments of $6.36 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10





